Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bach

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitorJ H Fleisch, C T Armstrong, C R Roman, et al.
Molecular Immunology|March 21, 2001
Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognitionD B De Oliveira, E Harfouch-Hammoud, H Otto, et al.
European Journal of Pharmacology|July 18, 1996
Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitorsN Fox, M Song, J Schrementi, et al.
Journal of Synchrotron Radiation|June 28, 2014
Characterization of spatial coherence of synchrotron radiation with non-redundant arrays of aperturesP Skopintsev, A Singer, J Bach, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPID W Snyder, N J Bach, R D Dillard, et al.
The Review of Scientific Instruments|June 8, 2013
Invited article: Coherent imaging using seeded free-electron laser pulses with variable polarization: first results and research opportunitiesF Capotondi, E Pedersoli, N Mahne, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeysG J Hom, M J Forrest, T J Bach, et al.
Journal of Medicinal Chemistry|December 20, 1996
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionalityR D Dillard, N J Bach, S E Draheim, et al.
Journal of Medicinal Chemistry|December 20, 1996
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamidesS E Draheim, N J Bach, R D Dillard, et al.
Journal of Medicinal Chemistry|December 20, 1996
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamidesR D Dillard, N J Bach, S E Draheim, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitorJ H Fleisch, C T Armstrong, C R Roman, et al.
Molecular Immunology|March 21, 2001
Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognitionD B De Oliveira, E Harfouch-Hammoud, H Otto, et al.
European Journal of Pharmacology|July 18, 1996
Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitorsN Fox, M Song, J Schrementi, et al.
Journal of Synchrotron Radiation|June 28, 2014
Characterization of spatial coherence of synchrotron radiation with non-redundant arrays of aperturesP Skopintsev, A Singer, J Bach, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPID W Snyder, N J Bach, R D Dillard, et al.
The Review of Scientific Instruments|June 8, 2013
Invited article: Coherent imaging using seeded free-electron laser pulses with variable polarization: first results and research opportunitiesF Capotondi, E Pedersoli, N Mahne, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeysG J Hom, M J Forrest, T J Bach, et al.
Journal of Medicinal Chemistry|December 20, 1996
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionalityR D Dillard, N J Bach, S E Draheim, et al.
Journal of Medicinal Chemistry|December 20, 1996
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamidesS E Draheim, N J Bach, R D Dillard, et al.
Journal of Medicinal Chemistry|December 20, 1996
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamidesR D Dillard, N J Bach, S E Draheim, et al.
Pageof 23